InvestorsHub Logo

Xrouter

11/29/14 11:17 AM

#26555 RE: furbush87 #26550

I feel it's almost time for another Seeking article with updates on recent developments. I look forward to reading them and increasing my limited knowledge on ONCS. My opinion is we should be well over a dollar right now,but due to the fact that the markets(in my opinion) are so corrupt, your guess is as good as mine. That's why I've always had a long holding in my best picks (which ONCS is one )as well as a fair amount of traders to buy and sell on ups and downs in order to put $$ in my pocket..I've been in and out of ONCS ever since INO spun it out their to relatives. At this point ,I feel ONCS is at its best and is still under the radar,but as it now looks,not for much longer,Strik

philospher42

11/29/14 1:49 PM

#26562 RE: furbush87 #26550

There are a few scenarios that get us to $20 this year. However, most of them are unlikely. The one real possibility is very good P2B results. Imagine the scenario at about the 6 month mark preliminary P2B results are outstanding. If the combo caused 90%+ systemic response rates the FDA would likely stop the trial given the known safety profile. The stock would rise to 20+ overnight on hype alone. I would not count on this scenario as real world results will most likely be less than the mouse models. The far fetched schemes to get to $20 would have odds of < 1%. This one is much better though as there is a very sound scientific rational. If forced, I would place the odds at about 10%, which is actually outstanding.